Cadrenal Therapeutics Common Stock (CVKD) Return On Assets

Annual ROA

-98.10%
0.00%

01 December 2023

CVKD ROA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly ROA

-118.40%
-36.16%-43.97%

01 September 2024

CVKD Quarterly ROA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CVKD ROA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+25.6%
3 y3 years--
5 y5 years--

CVKD ROA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat highat low-73.7%+73.3%
5 y5 yearsat highat low-73.7%+73.3%
alltimeall timeat highat low-73.7%+73.3%

Cadrenal Therapeutics Common Stock ROA History

DateAnnualQuarterly
Sept 2024
-
-118.40%(+44.0%)
June 2024
-
-82.24%(+20.6%)
Mar 2024
-
-68.17%(-47.2%)
Dec 2023
-98.10%
-129.21%(-18.8%)
Sept 2023
-
-159.13%(-48.3%)
DateAnnualQuarterly
June 2023
-
-307.66%(-30.6%)
Mar 2023
-
-443.17%(+35.8%)
Dec 2022
-
-326.42%(-24.5%)
Sept 2022
-
-432.36%(+55.0%)
June 2022
-
-278.96%

FAQ

  • What is Cadrenal Therapeutics Common Stock annual return on assets?
  • What is the all time high annual ROA for Cadrenal Therapeutics Common Stock?
  • What is Cadrenal Therapeutics Common Stock quarterly return on assets?
  • What is the all time high quarterly ROA for Cadrenal Therapeutics Common Stock?
  • What is Cadrenal Therapeutics Common Stock quarterly ROA year-on-year change?

What is Cadrenal Therapeutics Common Stock annual return on assets?

The current annual ROA of CVKD is -98.10%

What is the all time high annual ROA for Cadrenal Therapeutics Common Stock?

Cadrenal Therapeutics Common Stock all-time high annual return on assets is -98.10%

What is Cadrenal Therapeutics Common Stock quarterly return on assets?

The current quarterly ROA of CVKD is -118.40%

What is the all time high quarterly ROA for Cadrenal Therapeutics Common Stock?

Cadrenal Therapeutics Common Stock all-time high quarterly return on assets is -68.17%

What is Cadrenal Therapeutics Common Stock quarterly ROA year-on-year change?

Over the past year, CVKD quarterly return on assets has changed by +40.73% (+25.60%)